featured
Irinotecan Drug-Eluting Beads With Simultaneous FOLFOX Improves Outcomes of Patients With Colorectal Liver Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Controlled Trial of Irinotecan Drug-Eluting Beads With Simultaneous FOLFOX and Bevacizumab for Patients With Unresectable Colorectal Liver-Limited Metastasis
Cancer 2015 Jul 06;[EPub Ahead of Print], RC Martin, CR Scoggins, M Schreeder, WS Rilling, CJ Laing, CM Tatum, LR Kelly, RD Garcia-Monaco, VR Sharma, TS Crocenzi, SM StrasbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.